BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//www.barthsyndrome.org//NONSGML kigkonsult.se iCalcreator 2.30.10/
 /
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:00e9e3bb-266b-468c-b2b7-8f3a4b799b60
X-WR-CALDESC:Join us for Barth Syndrome Foundation’s virtual townhall on Ma
 y 23rd at 12pm ET to learn more about the valuable role that the worldwide
  Barth syndrome community will play in the FDA’s review of Stealth’s new d
 rug application (NDA) for elamipretide. \n\n\nAs a part of the FDA’s revie
 w\, the Barth Syndrome Foundation anticipates that the FDA’s Cardiovascula
 r and Renal Drugs Advisory Committee will convene a meeting in 2024 to rec
 ommend to the FDA whether the drug should be approved for use by people li
 ving with Barth syndrome. This Advisory Committee meeting will be a critic
 al opportunity for the personal experiences of our global community to be 
 heard and weighed in the regulatory decision-making process. \n\n \nBarth 
 families\, friends\, healthcare providers\, and all concerned and interest
 ed advocates are welcome and encouraged to attend.
X-WR-RELCALID:e2690a14d873a45e6e484c3320d9c227
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
TZNAME:EST
DTSTART:20231105T020000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RDATE:20241103T020000
RDATE:20251102T020000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:EDT
DTSTART:20240310T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RDATE:20250309T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:9f663864-6455-4128-bedc-7f22e2b7cb02
DTSTAMP:20260425T175026Z
DESCRIPTION:Join us for Barth Syndrome Foundation’s virtual townhall on May
  23rd at 12pm ET to learn more about the valuable role that the worldwide 
 Barth syndrome community will play in the FDA’s review of Stealth’s new dr
 ug application (NDA) for elamipretide. \n\n\nAs a part of the FDA’s review
 \, the Barth Syndrome Foundation anticipates that the FDA’s Cardiovascular
  and Renal Drugs Advisory Committee will convene a meeting in 2024 to reco
 mmend to the FDA whether the drug should be approved for use by people liv
 ing with Barth syndrome. This Advisory Committee meeting will be a critica
 l opportunity for the personal experiences of our global community to be h
 eard and weighed in the regulatory decision-making process. \n\n \nBarth f
 amilies\, friends\, healthcare providers\, and all concerned and intereste
 d advocates are welcome and encouraged to attend.
DTSTART;TZID=America/New_York:20240523T120000
DTEND;TZID=America/New_York:20240523T130000
LOCATION:https://barthsyndrome.zoom.us/meeting/register/tZUoceygpzIrGdFLgEZ
 huOSpTdqPLMNusHp1#/registration
SUMMARY:Essential Community Briefing
END:VEVENT
END:VCALENDAR
